PI3KCA, specifically, have been shown to be amplified and overexpressed in cases of high grade serous ovarian cancer (10, 11), while AKT and mTOR activation have been observed frequently in clear cell ovarian carcinoma (12). The gene discussed is AKT1; the disease is ovarian serous adenocarcinoma.